A Large‐scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|67|2|662-675

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.67, Iss.2, 2018-02, pp. : 662-675

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Detection and identification of peroxiredoxin 3 as a biomarker in hepatocellular carcinoma by a proteomic approach

By              

International Journal of Molecular Medicine, Vol. 29, Iss. 5, 2012-01 ,pp. : 832-840

Spandidos Publications

Access to resources Recommend Favorite

Natural History of T1N0M0 Hepatocellular Carcinoma: Large-Scale Study in the United States

By  

Oncology, Vol. 93, Iss. 4, 2017-07 ,pp. : 233-242

Karger

Access to resources Recommend Favorite

Clinical features associated with radiological response to sorafenib in unresectable hepatocellular carcinoma: a large multicenter study in Japan

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 5, 2015-05 ,pp. : 1581-1589

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinicopathological characteristics and oncological outcomes in patients with renal cell carcinoma registered in 2007: The first large‐scale multicenter study from the Cancer Registration Committee of the Japanese Urological Association

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 9, 2015-09 ,pp. : S1-S7

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biomarker Studies on Radiotherapy to Hepatocellular Carcinoma

By  

Oncology, Vol. 84, Iss. 1, 2013-02 ,pp. : 64-68

Karger

Access to resources Recommend Favorite